DG(14:0/22:2(13Z,16Z)/0:0)

Metabolite details

Identifier

IOYSFCVWNHOMJU-KAOSVWFWSA-N

InChI Key

IOYSFCVWNHOMJU-KAOSVWFWSA-N

IUPAC name

Preferred name

DG(14:0/22:2(13Z,16Z)/0:0)

INN name

—

Synonym

Diacylglycerol(14:0/22:2n6)

ChEBI

CHEBI:88788

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Metabolic characterization of the natural progression of chronic hepatitis B (Lipid assays).
• Industrial by-products as a novel circular source of biocompatible extracellular vesicles
• Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)

Observed in differential profiles

• non_COVID_19_healthy_vs_non_critical_COVID_19
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• Brewer_Spend_Yeast_vs_Whey
• G1_Ctrl_vs_G2_Ab